Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 838 for “"Amyloid beta"”.
-
The amyloid beta dimer/trimer: a potent stimulator of neuronal amyloid beta secretion and cofilin-actin rod formation
Amyloid beta (Aβ) peptides, a heterogeneous mixture of 39-43 amino acid peptides produced from β- and γ-secretase cleavage of the amyloid precursor protein (APP), are one of the causative agents of Alzheimer disease (AD). Although sensitive enzyme-linked immunosorbent assays (ELISAs) for specific …
-
SorLA and Amyloid Beta Expression in Glioma
… on its role in the pathological processing of amyloid precursor protein (APP) in Alzheimer’s disease. Reduced SorLA expression increases amyloidogenic APP cleavage to liberate toxic forms of amyloid beta (Aβ). A few recent reports have linked enhanced SorLA expression to various malignancies …
-
Endocannabinoids as Amyloid-Beta (Aβ) Aggregation Inhibitors
… hypothesized that endocannabinoids might reduce amyloid β-protein deposition and inhibit neuronal cell death through CB1 or other possible pathways. In vitro experiments, including cell studies using two cell lines (HTT22 and CB1-CHO), ThT based kinetic assay, and TEM studies were used to …
-
Inhibitors of Amyloid Beta Oligomerization and Toxicity
Neurotoxic aggregates of amyloid beta (Aβ) peptide contribute to the etiology of Alzheimer's disease (AD). Aβ1-42 forms oligomeric structures that undergo further aggregation into protofibrils and fibrils. Oligomeric Aβ1-42 is more toxic than monomers or mature fibrils. In this work, we used two …
-
Alzheimer's Disease and Amyloid Beta: Effects of amyloid beta on hippocampal and dorsal root ganglion neurons' electrophyiology and morphology
… Saskatchewan alone. AD results from pathological amyloid beta (Aβ) peptides that hamper neurons’ communication, cause progressive neuronal cell death in the central nervous system, and ultimately lead to memory loss in the individual. While disease symptoms are well known, the mechanism by which …
-
Effect of Gemini Surfactants on Amyloid Beta Aggregation
… and there is no cure which exists for it. In AD, Amyloid Beta (Aβ) peptides form aggregates that are neurotoxic in the brain. Hence, molecules that are able to prevent Aß aggregation could be effective in AD treatment. Gemini surfactant (GS) molecules consist of two hydrophilic heads separated by …
-
Mechanisms of Brain Region-Specific Amyloid-beta Deposition
… region-specific deposition of extracellular amyloid plaques principally comprised of the amyloid-β: Aβ) peptide. Using mouse models of cerebral Aβ deposition, we examined molecular, cellular and systems-level mechanisms that regulate brain region-specific Aβ accumulation and aggregation. …
-
A Dynamical Systems Analysis of Amyloid-Beta Production
… disease is characterized by the presence of beta-amyloid (A𝛽) plaques in the brain, caused by an accumulation of misfolded A𝛽 proteins. Research suggests that hallmark proteins involved in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral …
-
Specific amyloid-beta oligomers in-human cerebrospinal fluid.
… animals have suggested that soluble oligomers of amyloid-β (Aβ), such as Aβ*56, trimers, and dimers, are the synaptotoxic species in AD and are thought to be responsible for initiating the cognitive impairment associated with the early stages of disease. These studies also suggest that tau …
-
Ethynyl-1,1’-Biphenyl Derivatives as Amyloid Beta Aggregation Inhibitors
… AD is characterized by the formation of dense amyloid β (Aβ) plaques and neurofibrillary tangles (NFTs) in the central nervous system (CNS). The amyloid β cascade hypothesis states that an increase in insoluble amyloid β aggregates initiates the neurodegenerative cascade observed in AD. The …
-
Piperine Derivatives as Modulators of Amyloid-Beta (Aβ) Aggregation
… to AD is the aggregation of a protein known as amyloid-β (Aβ). However, most pharmacotherapies for AD provide only symptomatic relief and target other pathways. The recently approved monoclonal antibodies (mAbs) are the only disease-modifying therapies targeting Aβ peptide aggregation in AD that …
-
The Kinetics and Thermodynamics of the Amyloid Beta Peptide
Amyloids are a category of protein structures where many individual polypeptide chains fold to form long β-sheet fibrils. These are strongly associated to many of today's incurableand fatal diseases, such as Alzheimer's and Parkinson's disease. However, the exact cause of toxicity and disease …
-
Arylbenzamide and Arylcarboxamide Derivatives as Modulators of Amyloid-Beta Aggregation
… curative therapies. The recently launched anti-amyloid monoclonal antibodies hold promise although these are new to the market and their long-term benefits and potential disease-modifying effects are unknown. The global increases in the aging population and increasing life span mandate the need …
-
Novel 1,4-Diazepane Derivatives as Amyloid Beta (Aβ) Aggregation Inhibitors
… AD is primarily driven by the accumulation of amyloid-β (Aβ) plaques and tau tangles in the brain. The Aβ aggregation is indeed the primary pathological event, playing a key role in the initiation and progression of the disease. Despite extensive research, effective disease-modifying treatments …
-
Molecular Basis of Membrane Pore Formation by Amyloid Beta Peptide
… effective treatments are available for AD. The amyloid β (Aβ) peptide is neurotoxic and is tightly associated with AD pathology, but the molecular mechanism of its action remains unclear. There are various forms of Aβ in the brain, ranging from the full length Aβ1-42 to shorter peptides, such as …
-
Investigating the Amyloid-beta aggregation and oxidation using metal complexes
Amyloid-β (Aβ), a short peptide which self-assembles into large aggregates, was observed in the gray matter of Alzheimer’s patients. The aggregates in oligomeric and fibrillar forms were proven to be toxic to our brain. Based on this, many groups have taken on the task of investigating the …
-
Examining the binding of humanin and acetylcholinesterase with amyloid beta
The importance of amyloid-beta (Aβ) in the development and progression of Alzheimer’s disease (AD) is currently well-recognized. Aβ was recently shown to be protective against certain types of cancer and capable of inhibiting the growth of tumor cells. The mechanisms by which Aβ is converted into …
-
Using Image Translation To Synthesize Amyloid Beta From Structural MRI
Amyloid-beta and brain atrophy are known hallmarks of Alzheimer’s Disease (AD) and can be quantified with positron emission tomography (PET) and structural magnetic resonance imaging (MRI), respectively. PET uses radiotracers that bind to amyloid-beta, whereas MRI can measure brain morphology. PET …
-
Cellular mechanisms affecting Alzheimer’s amyloid-beta aggregation in Saccharomyces cerevisiae
Amyloid-beta (Aβ) plaques are a major neuropathological feature of Alzheimer's disease (AD). These plaques are primarily composed of aggregates of Aβ peptides generated via the amyloidogenic processing of the amyloid precursor protein. The two major isoforms of Aβ peptide are Aβ40 and Aβ42, of …
Page 1 of 42